Providing independent clinical excellence since 2005
By Juliette Martin, Nutritional Therapist: Over the past year, a family of medications called GLP-1 agonists, often referred to as the ‘skinny jab’ has captured widespread media attention.
This article looks into the role of PCSK9, the development of PCSK9 inhibitors, their efficiency, and their potential as a game-changer in the management of cardiovascular diseases. It provides a short exploration of the subject, drawing upon the most recent and relevant research and guidelines.
As we begin 2024, I want to highlight three groundbreaking developments from 2023 that promise a brighter future for healthcare, two of which leverage the power of artificial intelligence (AI).
Atrial fibrillation is a common but manageable heart rhythm condition. Understanding how it affects your heart rate, particularly during illness, empowers you to monitor changes early and work proactively with your doctor. With the right knowledge and self-care, you can confidently take control of your heart health.